US Stock MarketDetailed Quotes
ALNY Alnylam Pharmaceuticals
- 253.070
- -0.670-0.26%
Close Nov 29 13:00 ET
- 253.070
- 0.0000.00%
Post 16:05 ET
32.64BMarket Cap-96591P/E (TTM)
254.180High250.010Low325.55KVolume250.590Open253.740Pre Close82.23MTurnover0.25%Turnover RatioLossP/E (Static)128.98MShares304.39052wk High1008.25P/B32.50BFloat Cap141.97552wk Low--Dividend TTM128.44MShs Float304.390Historical High--Div YieldTTM1.64%Amplitude3.650Historical Low252.579Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Alnylam Pharmaceuticals Stock Forum
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet